ResearcherWeifang Medical UniversityActive in the last 2 years
Chengxia Kan
Matched on ORCID iD 0000-0002-4593-0303; OpenAlex author ID A5000398019.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 1, last author 0)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 2
2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper
Papers 2
- Targeting Glutamine Metabolic Reprogramming in Pancreatic Cancer: Current Insights and Future Directions. Co-author DOI 10.2174/0115680096357993241206072609↗
- Global, Regional, and National Burden of Pancreatic Cancer, 1990-2019: Results from the Global Burden of Disease Study 2019. First author DOI 10.5334/aogh.4019↗
Closest collaborators
The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Xiaodong Sun · 2 shared papers, 2023–2026
- Paper Targeting Glutamine Metabolic Reprogramming in Pancreatic Cancer: Current Insights and Future Directions. DOI 10.2174/0115680096357993241206072609↗
- Paper Global, Regional, and National Burden of Pancreatic Cancer, 1990-2019: Results from the Global Burden of Disease Study … DOI 10.5334/aogh.4019↗
- Yanhui Ma · 1 shared paper, 2026
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.